BRYCE RICHARD PAUL
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to BRYCE RICHARD PAUL. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PBYI | SEE REMARKS | Sale | 426 | $9.80 | $4,175 | Apr 5, 2021 |
| PBYI | SEE REMARKS | Sale | 422 | $10.15 | $4,283 | Mar 2, 2021 |
| PBYI | SEE REMARKS | Award / Grant | 52,846 | — | — | Feb 17, 2021 |
| PBYI | SEE REMARKS | Sale | 415 | $12.23 | $5,075 | Feb 2, 2021 |
| PBYI | SEE REMARKS | Sale | 6,548 | $10.23 | $66,986 | Jan 4, 2021 |
| PBYI | SEE REMARKS | Sale | 92 | $11.65 | $1,072 | Dec 2, 2020 |
| PBYI | SEE REMARKS | Sale | 97 | $7.81 | $758 | Nov 2, 2020 |
| PBYI | SEE REMARKS | Sale | 91 | $10.14 | $923 | Oct 2, 2020 |
| PBYI | SEE REMARKS | Sale | 90 | $9.77 | $879 | Sep 2, 2020 |
| PBYI | SEE REMARKS | Sale | 86 | $10.80 | $929 | Aug 3, 2020 |
| PBYI | SEE REMARKS | Sale | 660 | $10.67 | $7,042 | Jul 2, 2020 |
| PBYI | SEE REMARKS | Sale | 89 | $10.66 | $949 | Jun 2, 2020 |
| PBYI | SEE REMARKS | Sale | 89 | $9.62 | $856 | May 4, 2020 |
| PBYI | SEE REMARKS | Sale | 91 | $7.37 | $671 | Apr 2, 2020 |
| PBYI | SEE REMARKS | Sale | 96 | $10.02 | $962 | Mar 2, 2020 |
| PBYI | SEE REMARKS | Award / Grant | 43,274 | — | — | Feb 11, 2020 |
| PBYI | SEE REMARKS | Sale | 105 | $8.02 | $842 | Feb 3, 2020 |
| PBYI | SEE REMARKS | Sale | 2 | $8.36 | $17 | Jan 2, 2020 |
| PBYI | SEE REMARKS | Sale | 83 | $10.34 | $858 | Dec 2, 2019 |
| PBYI | SEE REMARKS | Sale | 88 | $7.38 | $649 | Nov 4, 2019 |
| PBYI | SEE REMARKS | Sale | 91 | $10.05 | $915 | Oct 2, 2019 |
| PBYI | SEE REMARKS | Sale | 95 | $10.11 | $960 | Sep 4, 2019 |
| PBYI | SEE REMARKS | Sale | 94 | $9.00 | $846 | Aug 2, 2019 |
| PBYI | SEE REMARKS | Sale | 1,841 | $10.10 | $18,594 | Jul 22, 2019 |
| PBYI | SEE REMARKS | Sale | 89 | $12.78 | $1,137 | Jul 2, 2019 |
| PBYI | SEE REMARKS | Sale | 88 | $15.07 | $1,326 | Jun 3, 2019 |
| PBYI | SEE REMARKS | Sale | 85 | $32.38 | $2,752 | May 2, 2019 |
| PBYI | SEE REMARKS | Sale | 88 | $35.78 | $3,149 | Apr 2, 2019 |
| PBYI | SEE REMARKS | Sale | 88 | $38.66 | $3,402 | Mar 4, 2019 |
| PBYI | SEE REMARKS | Award / Grant | 9,900 | — | — | Feb 6, 2019 |
| PBYI | SEE REMARKS | Sale | 89 | $27.77 | $2,472 | Feb 4, 2019 |
| PBYI | SEE REMARKS | Sale | 1,959 | $24.72 | $48,426 | Jan 22, 2019 |
| PBYI | SEE REMARKS | Sale | 1,210 | $20.67 | $25,011 | Jan 3, 2019 |
| PBYI | SEE REMARKS | Sale | 1,836 | $51.95 | $95,380 | Jul 20, 2018 |
| PBYI | SEE REMARKS | Award / Grant | 9,000 | — | — | Feb 11, 2018 |
| PBYI | SEE REMARKS | Award / Grant | 9,000 | — | — | Feb 11, 2018 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Sale | 1,860 | $92.75 | $172,515 | Jan 22, 2018 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Sale | 15,000 | $120.00 | $1,800,000 | Sep 29, 2017 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Sale | 14,000 | $100.10 | $1,401,400 | Sep 6, 2017 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Sale | 7 | $95.20 | $666 | Jul 20, 2017 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Option Exercise | 5,000 | $11.30 | $56,500 | Jul 3, 2017 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Sale | 2,293 | $33.24 | $76,219 | Jan 20, 2017 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Award / Grant | 31,500 | — | — | Oct 14, 2016 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Sale | 3,000 | $110.03 | $330,090 | Jul 6, 2015 |
| PBYI | SR VP, CLINICAL RESEARCH & DEV | Purchase | 28 | $82.49 | $2,310 | Apr 9, 2014 |